Cargando…

Persistence and Adherence to Cardiovascular Medicines in Australia

BACKGROUND: The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia. METHODS AND RESULTS: Using national dispensing claims f...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira Costa, Juliana, Lin, Jialing, Pearson, Sallie‐Anne, Buckley, Nicholas A., Schaffer, Andrea L., Falster, Michael O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356067/ https://www.ncbi.nlm.nih.gov/pubmed/37382104 http://dx.doi.org/10.1161/JAHA.122.030264

Ejemplares similares

A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)
por: Lin, Jialing, et al.
Publicado: (2023)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia
por: Bruno, Claudia, et al.
Publicado: (2020)

Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Evidence‐practice gaps in P2Y(12) inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population‐level data linkage in Australia
por: Falster, Michael O., et al.
Publicado: (2022)

Rates of Low-Value Service in Australian Public Hospitals and the Association With Patient Insurance Status
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians
por: Pearson, Sallie-Anne, et al.
Publicado: (2014)

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
por: Tang, Monica, et al.
Publicado: (2021)

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals
por: de Oliveira Costa, Juliana, et al.
Publicado: (2023)

Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia
por: Brett, Jonathan, et al.
Publicado: (2018)

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation
por: Schaffer, Andrea L., et al.
Publicado: (2019)

The changing face of Australian data reforms: impact on pharmacoepidemiology research
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia
por: Havard, Alys, et al.
Publicado: (2021)

Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
por: Daniels, Benjamin, et al.
Publicado: (2017)

Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
por: Morgan, Alice, et al.
Publicado: (2018)

Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients
por: Sotade, Oluwadamisola Temilade, et al.
Publicado: (2020)

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future
por: Pearson, Sallie-Anne, et al.
Publicado: (2021)

Anticholinergic medicines use among older adults before and after initiating dementia medicines
por: Narayan, Sujita W., et al.
Publicado: (2019)

Trends in self-poisoning and psychotropic drug use in people aged 5–19 years: a population-based retrospective cohort study in Australia
por: Cairns, Rose, et al.
Publicado: (2019)

Hospital characteristics associated with low-value care in public hospitals in New South Wales, Australia
por: Badgery-Parker, Tim, et al.
Publicado: (2020)

Association of Continuity of Primary Care and Statin Adherence
por: Warren, James R., et al.
Publicado: (2015)

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions
por: Schaffer, Andrea L., et al.
Publicado: (2021)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Visualising linked health data to explore health events around preventable hospitalisations in NSW Australia
por: Falster, Michael O, et al.
Publicado: (2016)

Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage
por: Stavrou, Efty P, et al.
Publicado: (2012)

Do hospitals influence geographic variation in admission for preventable hospitalisation? A data linkage study in New South Wales, Australia
por: Falster, Michael O, et al.
Publicado: (2019)

Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia
por: Tran, Bich, et al.
Publicado: (2016)

Medicine treatment of glaucoma in Australia 2012–2019: prevalence, incidence and persistence
por: Daniels, Benjamin, et al.
Publicado: (2021)

Gazing through time and beyond the health sector: Insights from a system dynamics model of cardiovascular disease in Australia
por: Peng, Cindy Q., et al.
Publicado: (2021)

Patterns of immediate breast reconstruction in New South Wales, Australia: a population‐based study
por: Feng, Yingyu, et al.
Publicado: (2019)

Inequalities in pediatric avoidable hospitalizations between Aboriginal and non-Aboriginal children in Australia: a population data linkage study
por: Falster, Kathleen, et al.
Publicado: (2016)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study
por: Chitty, Kate M, et al.
Publicado: (2020)

Social and geographical inequalities in school starting age in Australia: a population data linkage study
por: Hanly, Mark, et al.
Publicado: (2017)

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: a prospective cohort investigation among adults aged 45 years and over in Australia
por: Du, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jhv37u83kd5bb6qli4845ijcrt